Humanized antibody against S-surface antigen of hepatitis B virus
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 14, 2008
Grant Date -
Jan 19, 2006
app pub date -
Apr 7, 2005
filing date -
Apr 14, 2004
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
A humanized antibody of the present invention shows similar antigen-binding affinity to a mouse monoclonal antibody and significantly low immunogenecity. Therefore, the humanized antibody of the present invention can be effectively used for treating chronic hepatitis B and preventing HBV infection of a patient received liver transplantation and vertical transmission from a mother infected with HBV to a fetus.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully